HCPCS Level II code G0121 designates a screening colonoscopy for individuals who do not meet high-risk criteria for colorectal cancer. As a preventive screening code, it is widely used across outpatient endoscopy centers and hospital outpatient departments and plays a central role in national colorectal cancer screening efforts and quality measurement programs. Coverage and billing practices for G0121 affect access to preventive care, patient cost sharing, and population-level screening rates.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage approaches, coding and billing context, and common operational considerations for submitting G0121 claims. The publication also summarizes relevant benchmarking metrics, policy updates affecting preventive colonoscopy reimbursement and coverage, and clinical context distinguishing average-risk screening from diagnostic or high-risk procedures.

This resource is intended to inform billing professionals, health plan analysts, and clinical program managers about the role of HCPCS Level II code G0121 in national preventive care workflows, common payer interactions, and what to expect when reconciling screening versus diagnostic colorectal procedures. Data not available in the input for specific modifiers, associated taxonomies, and ICD-10 pairings is noted where applicable.